Day: April 21, 2018

Alere awarded grant to develop technologies for TB detection Alere Inc.

8 million situations of TB take place each full year, mostly in middle-income and low-income countries. Today, laboratory-based technologies provide the primary opportinity for diagnosing the condition, but these technologies frequently fail to identify large numbers of active cases, take weeks to provide results, lack crucial drug resistance information, or cannot meet the needs of individuals with limited usage of lab facilities. Alere's collaboration with the Gates Basis will produce a highly sensitive, low-cost diagnostic which can be implemented in lower-level laboratories or beyond your lab altogether. Read More